Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
News

iiCON Supports New Phase II Trial of Novel Pneumococcal Vaccine

The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine ...
Continue Reading →
News

Glox Therapeutics Awarded Grant to Accelerate Development of Precision Antibiotics

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 ...
Continue Reading →
News

LogiPharma Marks 25 Years in 2025 with Return to Lyon

LogiPharma, a life sciences supply chain event, is returning to Lyon in 2025 where it will celebrate its 25th anniversary. Hosted at the Palais des Congrès on 8 –...
Continue Reading →
News

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a somatostatin receptor 2 (SSTR2)-targeting ...
Continue Reading →
News

AstraZeneca Announces $3.5bn US Investment to Boost Research and Manufacturing

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by 2026. The funds will go towards a ...
Continue Reading →
Volume 16 Issue 2

Has AI Transformed Pharma’s Supply Chain? Pharmaceutical Packaging Expert Weighs In  

The pharmaceutical industry is consistently seeking to improve, and now, with the rise of advanced artificial intelligence (AI), the industry has pursued leveraging ...
Continue Reading →
Volume 16 Issue 2

The Development of Inhaled Products

Today, we have decades of development of inhaled products behind us. This development has led to the availability of very efficient products that have remarkably imp...
Continue Reading →
Volume 16 Issue 2

Advances in Intranasal Vaccine Delivery: A Promising Non-Invasive Route of Immunisation  

Vaccination is an effective weapon for disease prevention and has been proven to significantly reduce the transmission of infections and the number of deaths worldwi...
Continue Reading →
Volume 16 Issue 2

Accelerating the Go-To-Market of Nasal Combination Products with Integrated Solutions   

Ear, Nose, Throat Market Trends Outlook  The overall Ear, Nose, and Throat (ENT) market was heavily impacted by Covid-19 pandemic due to masks-wearing, lockd...
Continue Reading →
News

Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A

FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim8. Bags...
Continue Reading →
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025